Status:
COMPLETED
Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study
Lead Sponsor:
University of South Florida
Collaborating Sponsors:
Cambridge Health Alliance
Conditions:
Opioid-use Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Opioid overdoses are a significant problem nationwide and novel interventions that can prevent overdose by improving buprenorphine treatment for opioid use disorder are a public health priority. This ...
Detailed Description
The objective of this study is to evaluate an innovative strategy among opioid use disorder patients being discharged from detox. This study will evaluate the extent to which remote motivational enhan...
Eligibility Criteria
Inclusion
- age 18 to 65 years
- opioid use disorder
- stepping down from inpatient detox services
- willing to engage in daily outpatient supervised dosing of B/N.
Exclusion
- cognitively impaired (Unable to complete consent quiz at 90% accuracy AND MOCA \< 25/30 relative exclusion requiring PI approval, absolute exclusion for MOCA\<21/30)
- homeless
- reporting active homicidal or suicidal ideation with an imminent plan
- current mania or psychosis
- expected incarceration in next 3 months (those that are incarcerated during the study will be removed from the study)
- unable or unwilling to use a mobile device
- medical contraindication to BUP
- unable to complete baseline assessments
- unstable medical illness who expect hospitalization in the next 3 months pregnant women (if a patient becomes pregnant while participating in this study, they will be withdrawn)
- prisoners
- court-ordered individuals
- unable to speak or read English
Key Trial Info
Start Date :
July 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04449744
Start Date
July 13 2020
End Date
September 30 2021
Last Update
November 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ACTS Adult Addiction Receiving Facility (AARF)
Tampa, Florida, United States, 33610